Статті в журналах з теми "C3-convertase of alternative complement pathway"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "C3-convertase of alternative complement pathway".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Hourcade, Dennis E., Lynne M. Mitchell, and M. Edward Medof. "Decay acceleration of the complement alternative pathway C3 convertase." Immunopharmacology 42, no. 1-3 (May 1999): 167–73. http://dx.doi.org/10.1016/s0162-3109(99)00005-3.
Повний текст джерелаRoumenina, Lubka T., Mathieu Jablonski, Christophe Hue, Jacques Blouin, Jordan D. Dimitrov, Marie-Agnes Dragon-Durey, Mathieu Cayla, et al. "Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome." Blood 114, no. 13 (September 24, 2009): 2837–45. http://dx.doi.org/10.1182/blood-2009-01-197640.
Повний текст джерелаMullick, Jayati, John Bernet, Yogesh Panse, Sharanabasava Hallihosur, Akhilesh K. Singh, and Arvind Sahu. "Identification of Complement Regulatory Domains in Vaccinia Virus Complement Control Protein." Journal of Virology 79, no. 19 (October 1, 2005): 12382–93. http://dx.doi.org/10.1128/jvi.79.19.12382-12393.2005.
Повний текст джерелаSchwendinger, M. G., M. Spruth, J. Schoch, M. P. Dierich, and W. M. Prodinger. "A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells." Journal of Immunology 158, no. 11 (June 1, 1997): 5455–63. http://dx.doi.org/10.4049/jimmunol.158.11.5455.
Повний текст джерелаChauvet, Sophie, Romain Berthaud, Magali Devriese, Morgane Mignotet, Paula Vieira Martins, Tania Robe-Rybkine, Maria A. Miteva, et al. "Anti-Factor B Antibodies and Acute Postinfectious GN in Children." Journal of the American Society of Nephrology 31, no. 4 (February 7, 2020): 829–40. http://dx.doi.org/10.1681/asn.2019080851.
Повний текст джерелаWeiler, J. M., R. E. Edens, and G. J. Gleich. "Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway." Journal of Immunology 149, no. 2 (July 15, 1992): 643–48. http://dx.doi.org/10.4049/jimmunol.149.2.643.
Повний текст джерелаIrmscher, Sarah, Nadia Döring, Luke D. Halder, Emeraldo A. H. Jo, Isabell Kopka, Christine Dunker, Ilse D. Jacobsen, et al. "Kallikrein Cleaves C3 and Activates Complement." Journal of Innate Immunity 10, no. 2 (December 14, 2017): 94–105. http://dx.doi.org/10.1159/000484257.
Повний текст джерелаPangburn, M. K., and H. J. Müller-Eberhard. "The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase." Biochemical Journal 235, no. 3 (May 1, 1986): 723–30. http://dx.doi.org/10.1042/bj2350723.
Повний текст джерелаSahu, Arvind, Stuart N. Isaacs, Athena M. Soulika, and John D. Lambris. "Interaction of Vaccinia Virus Complement Control Protein with Human Complement Proteins: Factor I-Mediated Degradation of C3b to iC3b1 Inactivates the Alternative Complement Pathway." Journal of Immunology 160, no. 11 (June 1, 1998): 5596–604. http://dx.doi.org/10.4049/jimmunol.160.11.5596.
Повний текст джерелаJiang, Haixiang, Eric Wagner, Huamei Zhang, and Michael M. Frank. "Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway." Journal of Experimental Medicine 194, no. 11 (December 3, 2001): 1609–16. http://dx.doi.org/10.1084/jem.194.11.1609.
Повний текст джерелаJongerius, Ilse, Jörg Köhl, Manoj K. Pandey, Maartje Ruyken, Kok P. M. van Kessel, Jos A. G. van Strijp, and Suzan H. M. Rooijakkers. "Staphylococcal complement evasion by various convertase-blocking molecules." Journal of Experimental Medicine 204, no. 10 (September 24, 2007): 2461–71. http://dx.doi.org/10.1084/jem.20070818.
Повний текст джерелаAgostoni, A., M. Cicardi, M. Gardinali, and L. Bergamaschini. "The Complement System." International Journal of Immunopathology and Pharmacology 5, no. 2 (May 1992): 123–30. http://dx.doi.org/10.1177/039463209200500207.
Повний текст джерелаMichelfelder, Stefan, Friedericke Fischer, Astrid Wäldin, Kim V. Hörle, Martin Pohl, Juliana Parsons, Ralf Reski, et al. "The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential." Journal of the American Society of Nephrology 29, no. 4 (January 15, 2018): 1141–53. http://dx.doi.org/10.1681/asn.2017070738.
Повний текст джерелаInal, Jameel Malhador, Andreas Laich, and Sylvie Miot. "Complement C2 bypass mechanism involving the C3-convertase C4bBb (53.16)." Journal of Immunology 178, no. 1_Supplement (April 1, 2007): S106. http://dx.doi.org/10.4049/jimmunol.178.supp.53.16.
Повний текст джерелаWilcox, LA, JL Ezzell, NJ Bernshaw, and CJ Parker. "Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum." Blood 78, no. 3 (August 1, 1991): 820–29. http://dx.doi.org/10.1182/blood.v78.3.820.bloodjournal783820.
Повний текст джерелаNolasco, Jennifer, Leticia Nolasco, Qi Da, Sonya Cirlos, Zaverio Ruggeri, Joel Moake, and Miguel Cruz. "Complement Component C3 Binds to the A3 Domain of von Willebrand Factor." TH Open 02, no. 03 (July 2018): e338-e345. http://dx.doi.org/10.1055/s-0038-1672189.
Повний текст джерелаKinoshita, T., A. W. Dodds, S. K. A. Law, and K. Inoue. "The low C5 convertase activity of the C4A6 allotype of human complement component C4." Biochemical Journal 261, no. 3 (August 1, 1989): 743–48. http://dx.doi.org/10.1042/bj2610743.
Повний текст джерелаHindmarsh, Elizabeth J., and Rory M. Marks. "Complement Activation Occurs on Subendothelial Extracellular Matrix In Vitro and Is Initiated by Retraction or Removal of Overlying Endothelial Cells." Journal of Immunology 160, no. 12 (June 15, 1998): 6128–36. http://dx.doi.org/10.4049/jimmunol.160.12.6128.
Повний текст джерелаKinoshita, T., Y. Takata, H. Kozono, J. Takeda, K. S. Hong, and K. Inoue. "C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme." Journal of Immunology 141, no. 11 (December 1, 1988): 3895–901. http://dx.doi.org/10.4049/jimmunol.141.11.3895.
Повний текст джерелаIatropoulos, Paraskevas, Erica Daina, Manuela Curreri, Rossella Piras, Elisabetta Valoti, Caterina Mele, Elena Bresin, et al. "Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex–Mediated Membranoproliferative GN." Journal of the American Society of Nephrology 29, no. 1 (October 13, 2017): 283–94. http://dx.doi.org/10.1681/asn.2017030258.
Повний текст джерелаJELEZAROVA, Emiliana, Anna VOGT, and Hans U. LUTZ. "Interaction of C3b2–IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification." Biochemical Journal 349, no. 1 (June 26, 2000): 217–23. http://dx.doi.org/10.1042/bj3490217.
Повний текст джерелаMold, C., B. M. Bradt, G. R. Nemerow, and N. R. Cooper. "Epstein-Barr virus regulates activation and processing of the third component of complement." Journal of Experimental Medicine 168, no. 3 (September 1, 1988): 949–69. http://dx.doi.org/10.1084/jem.168.3.949.
Повний текст джерелаWilcox, LA, JL Ezzell, NJ Bernshaw, and CJ Parker. "Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum." Blood 78, no. 3 (August 1, 1991): 820–29. http://dx.doi.org/10.1182/blood.v78.3.820.820.
Повний текст джерелаMoulton, Elizabeth A., Paula Bertram, Nanhai Chen, R. Mark L. Buller, and John P. Atkinson. "Ectromelia Virus Inhibitor of Complement Enzymes Protects Intracellular Mature Virus and Infected Cells from Mouse Complement." Journal of Virology 84, no. 18 (July 7, 2010): 9128–39. http://dx.doi.org/10.1128/jvi.02677-09.
Повний текст джерелаKim, Y. U., T. Kinoshita, H. Molina, D. Hourcade, T. Seya, L. M. Wagner, and V. M. Holers. "Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein." Journal of Experimental Medicine 181, no. 1 (January 1, 1995): 151–59. http://dx.doi.org/10.1084/jem.181.1.151.
Повний текст джерелаMatsushita, M., and H. Okada. "Alternative complement pathway activation by C4b deposited during classical pathway activation." Journal of Immunology 136, no. 8 (April 15, 1986): 2994–98. http://dx.doi.org/10.4049/jimmunol.136.8.2994.
Повний текст джерелаMurray, Hannah, Beiying Qiu, Sze Yuan Ho, and Xiaomeng Wang. "Complement Factor B Mediates Ocular Angiogenesis through Regulating the VEGF Signaling Pathway." International Journal of Molecular Sciences 22, no. 17 (September 3, 2021): 9580. http://dx.doi.org/10.3390/ijms22179580.
Повний текст джерелаAlcorlo, M., A. Tortajada, S. Rodriguez de Cordoba, and O. Llorca. "Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin." Proceedings of the National Academy of Sciences 110, no. 33 (July 30, 2013): 13504–9. http://dx.doi.org/10.1073/pnas.1309618110.
Повний текст джерелаHolguin, M. H., C. B. Martin, N. J. Bernshaw, and C. J. Parker. "Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor." Journal of Immunology 148, no. 2 (January 15, 1992): 498–502. http://dx.doi.org/10.4049/jimmunol.148.2.498.
Повний текст джерелаManderson, Anthony P., Matthew C. Pickering, Marina Botto, Mark J. Walport, and Christopher R. Parish. "Continual Low-Level Activation of the Classical Complement Pathway." Journal of Experimental Medicine 194, no. 6 (September 10, 2001): 747–56. http://dx.doi.org/10.1084/jem.194.6.747.
Повний текст джерелаMeri, S., V. Koistinen, A. Miettinen, T. Törnroth, and I. J. Seppälä. "Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis." Journal of Experimental Medicine 175, no. 4 (April 1, 1992): 939–50. http://dx.doi.org/10.1084/jem.175.4.939.
Повний текст джерелаPedersen, Henrik, Rasmus K. Jensen, Annette G. Hansen, Trine A. F. Gadeberg, Steffen Thiel, Nick S. Laursen, and Gregers R. Andersen. "A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system." Journal of Biological Chemistry 295, no. 26 (May 6, 2020): 8746–58. http://dx.doi.org/10.1074/jbc.ra119.012339.
Повний текст джерелаRisitano, Antonio M., Patrizia Ricci, Caterina Pascariello, Maddalena Raia, Christoph Q. Schmidt, Yingxue Li, Edimara S. Reis, et al. "Novel Complement Modulators for Paroxysmal Nocturnal Hemoglobinuria: Peptide and Protein Inhibitors of C3 Convertase Prevent Both Surface C3 Deposition and Subsequent Hemolysis of Affected Erythrocytes in Vitro." Blood 120, no. 21 (November 16, 2012): 370. http://dx.doi.org/10.1182/blood.v120.21.370.370.
Повний текст джерелаHiramatsu, M., J. E. Balow, and G. C. Tsokos. "Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis." Journal of Immunology 136, no. 12 (June 15, 1986): 4451–55. http://dx.doi.org/10.4049/jimmunol.136.12.4451.
Повний текст джерелаSahu, A., B. K. Kay, and J. D. Lambris. "Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library." Journal of Immunology 157, no. 2 (July 15, 1996): 884–91. http://dx.doi.org/10.4049/jimmunol.157.2.884.
Повний текст джерелаFremeaux-Bacchi, Veronique, and Christoph Licht. "Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis." Thrombosis and Haemostasis 101, no. 02 (2009): 271–78. http://dx.doi.org/10.1160/th08-09-0575.
Повний текст джерелаLindorfer, Margaret A., Andrew W. Pawluczkowycz, Elizabeth M. Peek, Kimberly Hickman, Ronald P. Taylor, and Charles J. Parker. "A novel approach to preventing the hemolysis of paroxysmal nocturnal hemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement." Blood 115, no. 11 (March 18, 2010): 2283–91. http://dx.doi.org/10.1182/blood-2009-09-244285.
Повний текст джерелаCheung, A. K., C. J. Parker, J. Janatova, and E. Brynda. "Modulation of complement activation on hemodialysis membranes by immobilized heparin." Journal of the American Society of Nephrology 2, no. 8 (February 1992): 1328–37. http://dx.doi.org/10.1681/asn.v281328.
Повний текст джерелаFigueroa, J. E., and P. Densen. "Infectious diseases associated with complement deficiencies." Clinical Microbiology Reviews 4, no. 3 (July 1991): 359–95. http://dx.doi.org/10.1128/cmr.4.3.359.
Повний текст джерелаPangburn, M. K., and N. Rawal. "Structure and function of complement C5 convertase enzymes." Biochemical Society Transactions 30, no. 6 (November 1, 2002): 1006–10. http://dx.doi.org/10.1042/bst0301006.
Повний текст джерелаTaylor, Ronald P., Margaret A. Lindorfer, Andrew W. Pawluczkowycz, and Charles J. Parker. "A Novel Approach to Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH): Both Hemolysis and C3 Deposition Are Blocked by a Monoclonal Antibody (mAb) Specific for the Alternative Pathway of Complement (APC) C3/C5 Convertase." Blood 114, no. 22 (November 20, 2009): 157. http://dx.doi.org/10.1182/blood.v114.22.157.157.
Повний текст джерелаRawal, Nenoo, and Michael K. Pangburn. "C5 Convertase of the Alternative Pathway of Complement." Journal of Biological Chemistry 273, no. 27 (July 3, 1998): 16828–35. http://dx.doi.org/10.1074/jbc.273.27.16828.
Повний текст джерелаIwata, K., T. Seya, H. Ariga, and S. Nagasawa. "Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein." Journal of Immunology 152, no. 7 (April 1, 1994): 3436–44. http://dx.doi.org/10.4049/jimmunol.152.7.3436.
Повний текст джерелаTu, Anh-Hue T., Robert L. Fulgham, Mark A. McCrory, David E. Briles, and Alexander J. Szalai. "Pneumococcal Surface Protein A Inhibits Complement Activation by Streptococcus pneumoniae." Infection and Immunity 67, no. 9 (September 1, 1999): 4720–24. http://dx.doi.org/10.1128/iai.67.9.4720-4724.1999.
Повний текст джерелаISAAC, Lourdes, Dikran AIVAZIAN, Aiko TANIGUCHI-SIDLE, O. Roger EBANKS, S. Chuck FARAH, Marlene P. C. FLORIDO, K. Michael PANGBURN, and E. David ISENMAN. "Native conformations of human complement components C3 and C4 show different dependencies on thioester formation." Biochemical Journal 329, no. 3 (February 1, 1998): 705–12. http://dx.doi.org/10.1042/bj3290705.
Повний текст джерелаKimura, Yuko, Takashi Miwa, Lin Zhou, and Wen-Chao Song. "Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement." Blood 111, no. 2 (January 15, 2008): 732–40. http://dx.doi.org/10.1182/blood-2007-05-089821.
Повний текст джерелаKoistinen, V. "Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b." Biochemical Journal 280, no. 1 (November 15, 1991): 255–59. http://dx.doi.org/10.1042/bj2800255.
Повний текст джерелаRooijakkers, Suzan H. M., Jin Wu, Maartje Ruyken, Robert van Domselaar, Karel L. Planken, Apostolia Tzekou, Daniel Ricklin, et al. "Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor." Nature Immunology 10, no. 7 (June 7, 2009): 721–27. http://dx.doi.org/10.1038/ni.1756.
Повний текст джерелаJelezarova, Emiliana, and Hans U. Lutz. "IgG naturally occurring antibodies stabilize and promote the generation of the alternative complement pathway C3 convertase." Molecular Immunology 42, no. 11 (July 2005): 1393–403. http://dx.doi.org/10.1016/j.molimm.2004.12.014.
Повний текст джерелаRicklin, Daniel. "Manipulating the mediator: Modulation of the alternative complement pathway C3 convertase in health, disease and therapy." Immunobiology 217, no. 11 (November 2012): 1057–66. http://dx.doi.org/10.1016/j.imbio.2012.07.016.
Повний текст джерела